RNA degradation in antiviral immunity and autoimmunity

Trends in Immunology

Volumn 36, Issue 3, 2015, Pages 179-188

  Rigby, Rachel E ^a   Rehwinkel, Jan ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Aicardi Gouti res syndrome; MDA5; Nonsense mediated decay; Pattern recognition receptor; RNA exosome; Type I interferon

Indexed keywords

INTERFERON; MESSENGER RNA; RNA; EXOSOME MULTIENZYME RIBONUCLEASE COMPLEX; RIBONUCLEASE; VIRUS RNA;

AUTOIMMUNITY; EXOSOME; GENE CONTROL; NONSENSE MEDIATED MRNA DECAY; PLANT IMMUNITY; REVIEW; RNA DEGRADATION; RNA EDITING; RNA INTERFERENCE; RNA PROCESSING; VIRUS IMMUNITY; VIRUS INFECTION; GENETICS; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; NERVOUS SYSTEM MALFORMATION; NEUROLOGIC DISEASE; PATHOLOGY; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; VIRUS;

AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM; AUTOIMMUNITY; ENDORIBONUCLEASES; EXOSOME MULTIENZYME RIBONUCLEASE COMPLEX; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; INTERFERON TYPE I; LUPUS ERYTHEMATOSUS, SYSTEMIC; NERVOUS SYSTEM MALFORMATIONS; NONSENSE MEDIATED MRNA DECAY; RNA, VIRAL; SIGNAL TRANSDUCTION; VIRUSES;

EID: 84924177774     PISSN: 14714906     EISSN: 14714981     Source Type: Journal    
DOI: 10.1016/j.it.2015.02.001     Document Type: Review

References (111)

1. Garcia D., et al. Nonsense-mediated decay serves as a general viral restriction mechanism in plants. Cell Host Microbe 2014, 16:391-402.
2. Balistreri G., et al. The host nonsense-mediated mRNA decay pathway restricts Mammalian RNA virus replication. Cell Host Microbe 2014, 16:403-411.
3. Gloggnitzer J., et al. Nonsense-mediated mRNA decay modulates immune receptor levels to regulate plant antibacterial defense. Cell Host Microbe 2014, 16:376-390.
4. Eckard S.C., et al. The SKIV2L RNA exosome limits activation of the RIG-I-like receptors. Nat. Immunol. 2014, 15:839-845.
5. Behm-Ansmant I., et al. mRNA quality control: an ancient machinery recognizes and degrades mRNAs with nonsense codons. FEBS Lett. 2007, 581:2845-2853.
6. Huang L., Wilkinson M.F. Regulation of nonsense-mediated mRNA decay. Wiley Interdiscip. Rev. RNA 2012, 3:807-828.
7. Popp M.W., Maquat L.E. Organizing principles of mammalian nonsense-mediated mRNA decay. Annu. Rev. Genet. 2013, 47:139-165.
8. Kervestin S., Jacobson A. NMD: a multifaceted response to premature translational termination. Nat. Rev. Mol. Cell Biol. 2012, 13:700-712.
9. Bono F., Gehring N.H. Assembly, disassembly and recycling: the dynamics of exon junction complexes. RNA Biol. 2011, 8:24-29.
10. Makino D.L., et al. The RNA exosome and proteasome: common principles of degradation control. Nat. Rev. Mol. Cell Biol. 2013, 14:654-660.
11. Schneider C., Tollervey D. Threading the barrel of the RNA exosome. Trends Biochem. Sci. 2013, 38:485-493.
12. Hori K., Watanabe Y. UPF3 suppresses aberrant spliced mRNA in Arabidopsis. Plant J. 2005, 43:530-540.
13. Wittmann J., et al. hUPF2 silencing identifies physiologic substrates of mammalian nonsense-mediated mRNA decay. Mol. Cell. Biol. 2006, 26:1272-1287.
14. Rehwinkel J., et al. Nonsense-mediated mRNA decay factors act in concert to regulate common mRNA targets. RNA 2005, 11:1530-1544.
15. Ramani A.K., et al. High resolution transcriptome maps for wild-type and nonsense-mediated decay-defective Caenorhabditis elegans. Genome Biol. 2009, 10:R101.
16. Guan Q., et al. Impact of nonsense-mediated mRNA decay on the global expression profile of budding yeast. PLoS Genet. 2006, 2:e203.
17. Lelivelt M.J., Culbertson M.R. Yeast Upf proteins required for RNA surveillance affect global expression of the yeast transcriptome. Mol. Cell. Biol. 1999, 19:6710-6719.
18. Mendell J.T., et al. Nonsense surveillance regulates expression of diverse classes of mammalian transcripts and mutes genomic noise. Nat. Genet. 2004, 36:1073-1078.
19. Rehwinkel J., et al. Nonsense-mediated mRNA decay: Target genes and functional diversification of effectors. Trends Biochem. Sci. 2006, 31:639-646.
20. Fields B.N., et al. Fields virology 2007, Wolters Kluwer Health/Lippincott Williams & Wilkins.
21. Moon S.L., Wilusz J. Cytoplasmic viruses: rage against the (cellular RNA decay) machine. PLoS Pathog. 2013, 9:e1003762.
22. Mocquet V., et al. The human T-lymphotropic virus type 1 tax protein inhibits nonsense-mediated mRNA decay by interacting with INT6/EIF3E and UPF1. J. Virol. 2012, 86:7530-7543.
23. LeBlanc J.J., Beemon K.L. Unspliced Rous sarcoma virus genomic RNAs are translated and subjected to nonsense-mediated mRNA decay before packaging. J. Virol. 2004, 78:5139-5146.
24. Nakano K., et al. Viral interference with host mRNA surveillance, the nonsense-mediated mRNA decay (NMD) pathway, through a new function of HTLV-1 Rex: implications for retroviral replication. Microbes Infect. 2013, 15:491-505.
25. Hogg J.R., Goff S.P. Upf1 senses 3'UTR length to potentiate mRNA decay. Cell 2010, 143:379-389.
26. Quek B.L., Beemon K. Retroviral strategy to stabilize viral RNA. Curr. Opin. Microbiol. 2014, 18:78-82.
27. Weil J.E., Beemon K.L. A 3' UTR sequence stabilizes termination codons in the unspliced RNA of Rous sarcoma virus. RNA 2006, 12:102-110.
28. Ramage H.R., et al. A combined proteomics/genomics approach links hepatitis C virus infection with nonsense-mediated mRNA decay. Mol. Cell 2015, 57:329-340.
29. Graille M., Seraphin B. Surveillance pathways rescuing eukaryotic ribosomes lost in translation. Nat. Rev. Mol. Cell Biol. 2012, 13:727-735.
30. Firth A.E., Brierley I. Non-canonical translation in RNA viruses. J. Gen. Virol. 2012, 93:1385-1409.
31. Szittya G., Burgyan J. RNA interference-mediated intrinsic antiviral immunity in plants. Curr. Top. Microbiol. Immunol. 2013, 371:153-181.
32. Nayak A., et al. RNA interference-mediated intrinsic antiviral immunity in invertebrates. Curr. Top. Microbiol. Immunol. 2013, 371:183-200.
33. Maillard P.V., et al. Antiviral RNA interference in mammalian cells. Science 2013, 342:235-238.
34. Li Y., et al. RNA interference functions as an antiviral immunity mechanism in mammals. Science 2013, 342:231-234.
35. Schoggins J.W., et al. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 2011, 472:481-485.
36. Medzhitov R. Approaching the asymptote: 20 years later. Immunity 2009, 30:766-775.
37. Janeway C.A. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb. Symp. Quant. Biol. 1989, 54(Pt 1):1-13.
38. Vance R.E., et al. Patterns of pathogenesis: discrimination of pathogenic and nonpathogenic microbes by the innate immune system. Cell Host Microbe 2009, 6:10-21.
39. Matzinger P. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 1994, 12:991-1045.
40. Kumar H., et al. Pathogen recognition by the innate immune system. Int. Rev. Immunol. 2011, 30:16-34.
41. Cai X., et al. The cGAS-cGAMP-STING pathway of cytosolic DNA sensing and signaling. Mol. Cell 2014, 54:289-296.
42. Arciga-Reyes L., et al. UPF1 is required for nonsense-mediated mRNA decay (NMD) and RNAi in Arabidopsis. J. Cell Mol. Biol. 2006, 47:480-489.
43. Riehs N., et al. Arabidopsis SMG7 protein is required for exit from meiosis. J. Cell Sci. 2008, 121:2208-2216.
44. Yoine M., et al. Arabidopsis UPF1 RNA helicase for nonsense-mediated mRNA decay is involved in seed size control and is essential for growth. Plant Cell Physiol. 2006, 47:572-580.
45. Jeong H.J., et al. Nonsense-mediated mRNA decay factors, UPF1 and UPF3, contribute to plant defense. Plant Cell Physiol. 2011, 52:2147-2156.
46. Rayson S., et al. A role for nonsense-mediated mRNA decay in plants: pathogen responses are induced in Arabidopsis thaliana NMD mutants. PLoS ONE 2012, 7:e31917.
47. Riehs-Kearnan N., et al. Aberrant growth and lethality of Arabidopsis deficient in nonsense-mediated RNA decay factors is caused by autoimmune-like response. Nucleic Acids Res. 2012, 40:5615-5624.
48. Subramanian S., et al. A Tlr7 translocation accelerates systemic autoimmunity in murine lupus. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:9970-9975.
49. Pisitkun P., et al. Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science 2006, 312:1669-1672.
50. Crow Y.J. Type I interferonopathies: a novel set of inborn errors of immunity. Ann. N. Y. Acad. Sci. 2011, 1238:91-98.
51. Goubau D., et al. Cytosolic sensing of viruses. Immunity 2013, 38:855-869.
52. Versteeg G.A., Garcia-Sastre A. Viral tricks to grid-lock the type I interferon system. Curr. Opin. Microbiol. 2010, 13:508-516.
53. Hoffmann H.H. Interferons and viruses: an evolutionary arms race of molecular interactions. Trends Immunol. 2015, 36:124-138.
54. Ivashkiv L.B., Donlin L.T. Regulation of type I interferon responses. Nat. Rev. Immunol. 2014, 14:36-49.
55. Trinchieri G. Type I interferon: friend or foe?. J. Exp. Med. 2010, 207:2053-2063.
56. Liu Y., et al. Activated STING in a vascular and pulmonary syndrome. N. Engl. J. Med. 2014, 371:507-518.
57. Jeremiah N., et al. Inherited STING-activating mutation underlies a familial inflammatory syndrome with lupus-like manifestations. J. Clin. Invest. 2014, 124:5516-5520.
58. Rice G.I., et al. Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling. Nat. Genet. 2014, 46:503-509.
59. Oda H., et al. Aicardi-Goutieres syndrome is caused by IFIH1 mutations. Am. J. Hum. Genet. 2014, 95:121-125.
60. Funabiki M., et al. Autoimmune disorders associated with gain of function of the intracellular sensor MDA5. Immunity 2014, 40:199-212.
61. Volkman H.E., Stetson D.B. The enemy within: endogenous retroelements and autoimmune disease. Nat. Immunol. 2014, 15:415-422.
62. Ayinde D., et al. Restricting HIV the SAMHD1 way: through nucleotide starvation. Nat. Rev. Microbiol. 2012, 10:675-680.
63. Reijns M.A., Jackson A.P. Ribonuclease H2 in health and disease. Biochem. Soc. Trans. 2014, 42:717-725.
64. Samuel C.E. Adenosine deaminases acting on RNA (ADARs) are both antiviral and proviral. Virology 2011, 411:180-193.
65. George C.X., Samuel C.E. Human RNA-specific adenosine deaminase ADAR1 transcripts possess alternative exon 1 structures that initiate from different promoters, one constitutively active and the other interferon inducible. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:4621-4626.
66. Rice G.I., et al. Mutations in ADAR1 cause Aicardi-Goutieres syndrome associated with a type I interferon signature. Nat. Genet. 2012, 44:1243-1248.
67. Hartner J.C., et al. ADAR1 is essential for the maintenance of hematopoiesis and suppression of interferon signaling. Nat. Immunol. 2009, 10:109-115.
68. Hartner J.C., et al. Liver disintegration in the mouse embryo caused by deficiency in the RNA-editing enzyme ADAR1. J. Biol. Chem. 2004, 279:4894-4902.
69. Wang Q., et al. Stress-induced apoptosis associated with null mutation of ADAR1 RNA editing deaminase gene. J. Biol. Chem. 2004, 279:4952-4961.
70. Mannion N.M., et al. The RNA-Editing Enzyme ADAR1 Controls Innate Immune Responses to RNA. Cell Rep. 2014, 9:1482-1494.
71. Yang S., et al. Adenosine Deaminase Acting on RNA 1 Limits RIG-I RNA Detection and Suppresses IFN Production Responding to Viral and Endogenous RNAs. J. Immunol. 2014, 193:3436-3445.
72. Vitali P., Scadden A.D. Double-stranded RNAs containing multiple IU pairs are sufficient to suppress interferon induction and apoptosis. Nat. Struct. Mol. Biol. 2010, 17:1043-1050.
73. Hetz C. The unfolded protein response: controlling cell fate decisions under ER stress and beyond. Nat. Rev. Mol. Cell Biol. 2012, 13:89-102.
74. Hollien J., Weissman J.S. Decay of endoplasmic reticulum-localized mRNAs during the unfolded protein response. Science 2006, 313:104-107.
75. Gonzalez T.N., et al. Mechanism of non-spliceosomal mRNA splicing in the unfolded protein response pathway. EMBO J. 1999, 18:3119-3132.
76. Cho J.A., et al. The unfolded protein response element IRE1alpha senses bacterial proteins invading the ER to activate RIG-I and innate immune signaling. Cell Host Microbe 2013, 13:558-569.
77. Fernando M.M., et al. Identification of two independent risk factors for lupus within the MHC in United Kingdom families. PLoS Genet. 2007, 3:e192.
78. Crow Y.J., et al. Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 cause Aicardi-Goutieres syndrome at the AGS1 locus. Nat. Genet. 2006, 38:917-920.
79. Lee-Kirsch M.A., et al. Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 are associated with systemic lupus erythematosus. Nat. Genet. 2007, 39:1065-1067.
80. Hasan M., Yan N. Safeguard against DNA sensing: the role of TREX1 in HIV-1 infection and autoimmune diseases. Front. Microbiol. 2014, 5:193.
81. McGonagle D., McDermott M.F. A proposed classification of the immunological diseases. PLoS Med. 2006, 3:e297.
82. Lejeune F., et al. The exon junction complex is detected on CBP80-bound but not eIF4E-bound mRNA in mammalian cells: dynamics of mRNP remodeling. EMBO J. 2002, 21:3536-3545.
83. Dostie J., Dreyfuss G. Translation is required to remove Y14 from mRNAs in the cytoplasm. Curr. Biol. 2002, 12:1060-1067.
84. Maquat L.E., et al. The pioneer round of translation: features and functions. Cell 2010, 142:368-374.
85. Buhler M., et al. EJC-independent degradation of nonsense immunoglobulin-mu mRNA depends on 3' UTR length. Nat. Struct. Mol. Biol. 2006, 13:462-464.
86. Kertesz S., et al. Both introns and long 3'-UTRs operate as cis-acting elements to trigger nonsense-mediated decay in plants. Nucleic Acids Res. 2006, 34:6147-6157.
87. Behm-Ansmant I., et al. A conserved role for cytoplasmic poly(A)-binding protein 1 (PABPC1) in nonsense-mediated mRNA decay. EMBO J. 2007, 26:1591-1601.
88. Wilson R.C., Doudna J.A. Molecular mechanisms of RNA interference. Annu. Rev. Biophys. 2013, 42:217-239.
89. Weber F., et al. Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses. J. Virol. 2006, 80:5059-5064.
90. Cullen B.R., et al. Is RNA interference a physiologically relevant innate antiviral immune response in mammals?. Cell Host Microbe 2013, 14:374-378.
91. Shapiro J.S., et al. Drosha as an interferon-independent antiviral factor. Proc. Natl Acad. Sci. U.S.A. 2014, 111:7108-7113.
92. Backes S., et al. The Mammalian response to virus infection is independent of small RNA silencing. Cell Rep. 2014, 8:114-125.
93. Ding S.W., Voinnet O. Antiviral RNA silencing in mammals: no news is not good news. Cell Rep. 2014, 9:795-797.
94. tenOever B.R. Response to Voinnet et al. Cell Rep. 2014, 9:798-799.
95. Macho A.P., Zipfel C. Plant PRRs and the activation of innate immune signaling. Mol. Cell 2014, 54:263-272.
96. Zipfel C. Plant pattern-recognition receptors. Trends Immunol. 2014, 35:345-351.
97. Mandadi K.K., Scholthof K.B. Plant immune responses against viruses: how does a virus cause disease?. Plant Cell 2013, 25:1489-1505.
98. Tsuda K., Katagiri F. Comparing signaling mechanisms engaged in pattern-triggered and effector-triggered immunity. Curr. Opin. Plant Biol. 2010, 13:459-465.
99. Ausubel F.M. Are innate immune signaling pathways in plants and animals conserved?. Nat. Immunol. 2005, 6:973-979.
100. Griebel T., et al. NOD-like receptor cooperativity in effector-triggered immunity. Trends Immunol. 2014, 35:562-570.
101. DeYoung B.J., Innes R.W. Plant NBS-LRR proteins in pathogen sensing and host defense. Nat. Immunol. 2006, 7:1243-1249.
102. Heidrich K., et al. Molecular and spatial constraints on NB-LRR receptor signaling. Curr. Opin. Plant Biol. 2012, 15:385-391.
103. Rice G., et al. Heterozygous mutations in TREX1 cause familial chilblain lupus and dominant Aicardi-Goutieres syndrome. Am. J. Hum. Genet. 2007, 80:811-815.
104. Pizzi S., et al. Reduction of hRNase H2 activity in Aicardi-Goutieres syndrome cells leads to replication stress and genome instability. Hum. Mol. Genet. 2015, 24:649-658.
105. Crow Y.J., et al. Mutations in genes encoding ribonuclease H2 subunits cause Aicardi-Goutieres syndrome and mimic congenital viral brain infection. Nat. Genet. 2006, 38:910-916.
106. Rice G.I., et al. Mutations involved in Aicardi-Goutieres syndrome implicate SAMHD1 as regulator of the innate immune response. Nat. Genet. 2009, 41:829-832.
107. Zhang X., et al. Human intracellular ISG15 prevents interferon-alpha/beta over-amplification and auto-inflammation. Nature 2015, 517:89-93.
108. Xin B., et al. Homozygous mutation in SAMHD1 gene causes cerebral vasculopathy and early onset stroke. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:5372-5377.
109. Rutsch F., et al. A Specific IFIH1 Gain-of-function Mutation Causes Singleton-Merten Syndrome. Am. J. Hum. Genet. 2015, 96:275-282.
110. Crow Y.J. Type I interferonopathies: mendelian type I interferon up-regulation. Curr. Opin. Immunol. 2015, 32:7-12.
111. Crow Y.J., et al. Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1. Am. J. Hum. Genet. A 2015, 167A:296-312.